Toprol Xl

Rediff.com » News » Toprol Xl

News for Toprol Xl

Business

Why drug firms' Q2 revenue growth is likely to dip

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating......

Investors concerned about Wockhardt

Will Wockhardt be the next Ranbaxy? This is being asked in the backdrop of the company being under the scrutiny of both the American and British drug regulators.First came an import alert from the......

Dr Reddy's: New launches to drive growth

Dr Reddy’s Laboratories (DRL) has surged nearly 21% from its closing low of Rs 1,737.60 on March 01, 2013 on the back of increased traction in approvals from the US Food and Drug......

Wockhardt set to join billion-dollar club

Wockhardt, the pharmacautical major, is expected to join the billion-dollar (Rs 5,400 crore) revenue club by the month-end, with half of this inflow from America, Chairman Habil Khorakiwala said on......

Wockhardt receives US nod for cardiac drug

Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug. Wockhardt will be marketing 25 mg, 50......

Rediff News

Toprol Xl

News for Toprol Xl

Why drug firms' Q2 revenue growth is likely to dip

Investors concerned about Wockhardt

Dr Reddy's: New launches to drive growth

Wockhardt set to join billion-dollar club

Wockhardt receives US nod for cardiac drug

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS